Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check7 days agoChange DetectedRevision history updated: added entry v3.4.3 and removed entry v3.4.2 to reflect the latest submission.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.4.2 was added to the history; the government funding lapse notice and the v3.4.1 revision entry were removed.SummaryDifference0.8%

- Check43 days agoChange DetectedThe page history shows a government funding notice being added and a revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check50 days agoChange DetectedUI enhancements to the history page include a Show glossary option, green highlights for additions, red highlights for deletions, and explanatory color-coding text; the revision label updates from v3.3.4 to v3.4.0.SummaryDifference1%

- Check64 days agoChange DetectedThe record history now shows a new revision entry: v3.3.4. The previous revision entry v3.3.3 has been removed from the list.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.3 is added to the record history; HHS Vulnerability Disclosure and Revision: v3.3.2 entries are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.